Concepedia
Statistics
Publications
10
Citations
253
H-Index
Active since
2020
Affiliations
University of California, San Francisco(Current)
UCSF Helen Diller Family Comprehensive Cancer Center
University of California System
University of Virginia Medical Center
University of California, Berkeley
Anju Wadhwa is an author at University of California, San Francisco specializing in oncology, medicine, and theranostics.
Publications per year
2020–2025
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
Anil P. Bidkar, Sinan Wang, Kondapa Naidu Bobba et al. · Clinical Cancer Research · 2023 · 49 citations · Full text
Medicine, Oncology, Pharmacology +17
<i>In silico</i> Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19
Cheryl Sachdeva, Anju Wadhwa, Anita Kumari et al. · OMICS A Journal of Integrative Biology · 2020 · 46 citations
Pharmacy, Infectious Diseases, Pharmacology +14
Evaluation of<sup>134</sup>Ce/<sup>134</sup>La as a PET Imaging Theranostic Pair for<sup>225</sup>Ac α-Radiotherapeutics
Kondapa Naidu Bobba, Anil P. Bidkar, Niranjan Meher et al. · Journal of Nuclear Medicine · 2023 · 37 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma
Anju Wadhwa, Sinan Wang, Bonell Patiño-Escobar et al. · Clinical Cancer Research · 2023 · 28 citations · Full text
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5
Kondapa Naidu Bobba, Anil P. Bidkar, Anju Wadhwa et al. · Theranostics · 2024 · 27 citations · Full text
1–5 of 10